Larimar Therapeutics, Inc.

LRMR

Larimar Therapeutics, Inc.

LRMR

Insider Sentiment (TTM):

Last Purchase:2026-02-27Last Sale:-Shares Purchased (TTM):5,110,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:87,156,133Shares Outstanding:89,814,820Institutional Ownership Pct.:97.04%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	93	178	85	90	21	21	33	35	32	110	27	39
Available For Sale Securities Debt Securities Curr…	64	22	51	85	118	136	150	169	194	117	60	57
Prepaid Expense And Other Assets Current	4	5	5	8	7	8	12	10	5	4	3	3
Assets Current	161	205	142	183	146	165	195	213	231	231	90	98
Available For Sale Securities Debt Securities Nonc…	-	-	-	-	-	-	-	-	-	12	-	-
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	3	2	2	2	2	3	3	3	3	3	3	3
Restricted Cash Noncurrent	0	1	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	0	1	1	1	1	1	1	1	1	1	1	1
Assets	165	209	146	187	150	170	200	219	237	248	96	104
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	8	9	5	11	4	2	2	2	3	2	1	1
Accrued Liabilities Current	25	38	58	33	21	19	21	14	17	10	7	5
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Liabilities Current	34	48	65	45	27	22	24	16	21	13	10	7
Operating Lease Liability Noncurrent	4	3	3	3	3	4	4	4	5	5	5	5
Liabilities	38	50	68	48	30	26	28	21	26	17	14	11
Stockholders Equity
Preferred Stock Value	0	0	-	-	-	-	-	-	-	-	-	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	625	622	513	511	444	443	441	438	436	434	270	268
Retained Earnings Accumulated Deficit	-497	-464	-435	-372	-325	-298	-269	-240	-225	-203	-189	-176
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	0	-0	0	0	0	-0	-0	0	0
Stockholders Equity	127	158	78	139	120	144	172	198	211	231	82	93
Liabilities And Stockholders Equity	165	209	146	187	150	170	200	219	237	248	96	104
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	1	1	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	1	1	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	215	115	115	115	115	115	115	115	115	115	115	115
Common Stock Shares Issued	104	104	83	86	64	64	64	64	64	64	44	44
Shares Outstanding	104	104	83	86	64	64	64	64	64	64	44	44

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-18.51%	-16.20%	-1.80%	-	-	-	-	-	-	-	-	-
2025	-29.43%	-2.26%	21.13%	-7.51%	14.32%	-8.69%	9.94%	22.05%	14.60%	8.50%	-11.19%	-29.08%
2024	1.78%	-7.76%	21.12%	6.32%	-11.69%	7.66%	-27.19%	-52.60%	-60.52%	-16.23%	-13.16%	26.32%
2023	-	-	-	0.52%	3.67%	-30.18%	35.55%	82.81%	140.23%	-14.43%	-10.70%	-7.99%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.70	4.29	2.19	4.06	5.46	7.48	8.02	13.10	10.93	17.99	9.49	15.02
Quick Ratio	4.57	4.20	2.11	3.89	5.20	7.12	7.53	12.51	10.69	17.70	9.13	14.58
Working Capital	126.51M	157.22M	77.23M	138.11M	118.91M	143.35M	170.95M	196.97M	209.98M	218.11M	80.67M	91.92M
Leverage & Debt
Debt to Equity	0.30	0.32	0.87	0.35	0.25	0.18	0.17	0.10	0.12	0.08	0.17	0.12
Debt Ratio	0.23	0.24	0.46	0.26	0.20	0.15	0.14	0.09	0.11	0.07	0.15	0.11
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-	-1.85	-2.27	-1.69	-1.56	-1.49	-1.32	-1.02	-0.91	-0.84	-0.84	-0.76
Free Cash Flow Per Share TTM	-0.86	-0.71	-0.63	-0.87	-1.45	-1.37	-1.16	-0.92	-0.68	-0.68	-0.76	-0.70
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	72.98%	74.32%	105.54%	103.79%	71.05%	111.26%	118.15%	94.04%	78.75%	36.85%	4.51%	-4.80%
EPS Growth (1Y)	6.61%	24.15%	72.60%	66.01%	70.44%	76.88%	56.34%	33.52%	22.98%	12.18%	-38.67%	-51.80%
Valuation Metrics
P/E TTM	-1.84	-2.43	-1.68	-1.92	-1.85	-1.44	-2.94	-6.45	-7.93	-9.02	-5.41	-5.20
P/B TTM	2.49	2.56	3.56	1.82	1.54	0.95	1.38	2.11	2.19	1.76	2.44	1.87
Market Cap	316.84M	404.17M	277.93M	252.99M	185.04M	137.52M	237.06M	417.93M	462.56M	406.47M	199.75M	173.42M
Enterprise Value	224.16M	226.25M	192.52M	162.85M	164.45M	116.40M	203.84M	382.86M	430.25M	296.35M	173.00M	134.70M
Calculated Values
Free Cash Flow TTM	-88.85M	-64.14M	-46.11M	-68.06M	-92.64M	-87.45M	-71.28M	-58.62M	-43.22M	-36.32M	-33.46M	-30.79M
Net Debt	-92.69M	-177.91M	-85.41M	-90.14M	-20.59M	-21.13M	-33.22M	-35.07M	-32.31M	-110.13M	-26.75M	-38.72M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-27Purchase

Owner: Deerfield, Mgmt Hif, L.P.…

Title: -

Shares: 5,000,000

Price/Share: $5.00

Value: $25,000,000.00

Shares Owned: 10,622,957

Relationship: Director,TenPercentOwner,Other

Ownership: Indirect

2026-02-27Purchase

Owner: Thomas, Frank E

Title: -

Shares: 5,000

Price/Share: $5.00

Value: $25,000.00

Shares Owned: 7,000

Relationship: Director

Ownership: Direct

2026-02-27Purchase

Owner: Sherman, Jeffrey W

Title: -

Shares: 5,000

Price/Share: $5.00

Value: $25,000.00

Shares Owned: 5,000

Relationship: Director

Ownership: Direct

2026-02-27Purchase

Owner: Hamilton, Thomas Edward

Title: -

Shares: 100,000

Price/Share: $5.00

Value: $500,000.00

Shares Owned: 664,798

Relationship: Director

Ownership: Direct

2025-07-31Purchase

Owner: Deerfield, Mgmt Hif, L.P.…

Title: -

Shares: 9,375,000

Price/Share: $3.20

Value: $30,000,000.00

Shares Owned: 9,538,945

Relationship: Director,TenPercentOwner,Other

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-27	Deerfield, Mgmt Hif, L.P.…	Director,TenPercentOwner,Other	-	Indirect	Purchase	5,000,000	5.00	$25,000,000.00	10,622,957	4
2026-02-27	Thomas, Frank E	Director	-	Direct	Purchase	5,000	5.00	$25,000.00	7,000	4
2026-02-27	Sherman, Jeffrey W	Director	-	Direct	Purchase	5,000	5.00	$25,000.00	5,000	4
2026-02-27	Hamilton, Thomas Edward	Director	-	Direct	Purchase	100,000	5.00	$500,000.00	664,798	4
2025-07-31	Deerfield, Mgmt Hif, L.P.…	Director,TenPercentOwner,Other	-	Indirect	Purchase	9,375,000	3.20	$30,000,000.00	9,538,945	4
2024-02-16	Deerfield, Mgmt L.P., Fly…	Director,TenPercentOwner,Other	-	Indirect	Purchase	4,290,617	8.74	$37,499,992.58	6,151,406	4
2024-02-16	Hamilton, Thomas Edward	Director	-	Direct	Purchase	57,208	8.74	$499,997.92	564,798	4
2024-02-14	Thomas, Frank E	Director	-	Direct	Purchase	2,000	11.00	$22,000.00	2,000	4
2023-12-07	Shankar, Gopi	Officer	Chief Development Officer	Direct	Purchase	5,000	3.73	$18,650.00	5,000	4
2023-05-17	Ben-Maimon, Carole	Director,Officer	President and CEO	Direct	Purchase	5,000	3.71	$18,550.00	266,829	4
2023-05-17	Celano, Michael	Officer	Chief Financial Officer	Direct	Purchase	5,000	3.73	$18,650.00	112,746	4
2023-05-17	Truitt, Joseph	Director	-	Direct	Purchase	2,750	3.73	$10,257.50	2,750	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

97.04%

Inst. Shares: 87,156,133

Shares Outstanding: 89,814,820

2025-12-31

98.95%

Inst. Shares: 72,183,269

Shares Outstanding: 72,947,927

2025-09-30

108.60%

Inst. Shares: 85,063,551

Shares Outstanding: 78,324,767

2025-06-30

96.60%

Inst. Shares: 61,854,022

Shares Outstanding: 64,027,892

2025-03-31

94.81%

Inst. Shares: 60,646,497

Shares Outstanding: 63,964,008

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	87,156,133	89,814,820	97.04%
2025-12-31	72,183,269	72,947,927	98.95%
2025-09-30	85,063,551	78,324,767	108.60%
2025-06-30	61,854,022	64,027,892	96.60%
2025-03-31	60,646,497	63,964,008	94.81%
2024-12-31	63,153,514	61,256,084	103.10%
2024-09-30	63,872,806	63,806,158	100.10%
2024-06-30	65,167,751	63,801,792	102.14%
2024-03-31	62,950,749	53,553,707	117.55%
2023-12-31	39,097,907	43,901,241	89.06%
2023-09-30	38,344,686	43,903,738	87.34%
2023-06-30	38,471,001	43,897,603	87.64%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Larimar Therapeutics, Inc. (LRMR) — SEC Financial Statements & Analysis

Larimar Therapeutics, Inc. (LRMR) is a pharmaceutical preparations company, incorporated in DE. Larimar Therapeutics, Inc. trades on Nasdaq as: LRMR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Larimar Therapeutics, Inc. reported a Debt-to-Equity ratio of 0.30x, a Price-to-Book (P/B) ratio of 2.49x (TTM), at a market cap of $316.84M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.30x
P/B TTM: 2.49x
Market Cap: $316.84M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Larimar Therapeutics, Inc. in?

Larimar Therapeutics, Inc. (LRMR) operates in the Pharmaceutical Preparations industry.

What is LRMR's market cap?

Larimar Therapeutics, Inc. (LRMR) has a market capitalization of $316.84M as of 2026-06-30.

What exchange does LRMR trade on?

Larimar Therapeutics, Inc. (LRMR) trades on the Nasdaq.

Where is Larimar Therapeutics, Inc. incorporated?

Larimar Therapeutics, Inc. is incorporated in DE.